Those who are eligible - including individuals aged five years and over who are immunosuppressed - will be offered the vaccine roughly six months after their last dose.

The Pfizer, Moderna, Sanofi/GSK vaccines are among the options available. Which vaccine people receive will depend on local supply.

The Novavax jab will also be available for use only when alternatives are not considered clinically suitable.

Those eligible under 12 will be offered a children's version of the Pfizer/BioNTech vaccine.

Professor Wei Shen Lim, chair of the Joint Committee on Vaccination and Immunisation's (JCVI) COVID-19 Committee, said: "Vaccination remains the best way to protect yourself against COVID-19 and the spring booster programme provides an opportunity for those who are at highest risk of severe illness to keep their immunity topped up.

"This year's spring programme will bridge the gap to the planned booster programme in the autumn, enabling those who are most vulnerable to be well protected throughout the summer."

Read more:
Matt Hancock is 'two-faced' and 'was like a headless chicken' during COVID vaccine drive
WHO says all theories for COVID origin 'remain on table' as lab leak theory gains traction

Dr Mary Ramsay, head of immunisation at the UK Health Security Agency, said: "COVID-19 is still circulating widely, and we have recently seen increases in older people being hospitalised.

"It is important those at highest risk of severe illness do not become complacent and I would encourage everyone who is eligible to come forward once the booster programme starts," she said.

NHS England will set out the specific details of the programme at a later date.